Food and Drug Administration (FDA) approved oral semaglutide in September 2019 for use in adults with type 2 diabetes
Another approach involves modifying Lactobacillus plantarum to produce native GLP-1, which was shown to improve metabolic parameters, reduce inflammation, and restore -cell function in HFD/STZ mouse models of T2DM (Hu et al., 2023)
Weight loss as a result of GLP-1s, when medically appropriate, can result in health benefits like lower blood pressure, a lower risk of developing type 2 diabetes, improved sleep and, in some cases, an overall improved quality of life
Commitment to Lifestyle Changes: You are prepared for permanent changes to diet and exercise
Start your intake How Semaglutide Affects Digestive Motility Semaglutide activates GLP-1 receptors throughout the gastrointestinal tract, including the stomach and small intestine
But doing it safely is the most important thing of all